CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market sale CEO and President sold 50,000 shares at $5.11 ($255,310)
- DEFA14A Proxy Proxy Materials
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 4,132 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 6,492 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Innovation/Tech Officer sold 40,000 shares at $5.00 ($200,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Innovation/Tech Officer sold 80,000 shares at an average $3.85 ($308,000)
- 4 Open-market sale Chief Innovation/Tech Officer sold 40,000 shares at $4.50 ($180,000)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
Page 25 of 35 · 690 filings